packageDapagliflozin
dapagliflozin
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Dapagliflozin is a blood-glucose-lowering medicine (an SGLT2 inhibitor) used to treat type 2 diabetes, and also heart failure and chronic kidney disease. It is widely used and authorised in the European Union, available both alone and in combination products.
Summary written by glm-5.3-flash from Wikidata Q409898 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | dapagliflozin |
| ATC codes: | A10BK01 |
| DrugBank: | DB06292 |
| PubChem CID: | 9887712 |
| ChEBI: | 85078 |
| Wikidata: | Q409898 |
| formula: | C21H25ClO6 |
| molar mass: | 408.875 g/mol (PubChem CID 9887712) |
| logP: | 2.3 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |